Long-term stability studies on protection against Newcastle disease by commercial live vaccine used in Brazil.
The thermostability (TS) and efficacy offered by live vaccines against Newcastle disease strains B1, La Sota, VG-GA and Ulster, produced or imported by four Brazilian laboratories, were evaluated during their validity period. Kinetic profiles were obtained from samples conserved in refrigerators during 0, 4, 8, 12, 16, 20 and 24 months after their manufacturing. The statistical analysis of the vaccine titre effect obtained by the fresh air (FA) method showed that the vaccine profiles were parallel and coincident, presenting a significant descending trend. The vaccine titres and efficiency proofs at the end of the validity period were above the level of legislation requirements and showed an average loss in titre of 0.40 and 0.66 log(10,) within the first and second validity years, respectively. The titre obtained by TS, within the month after manufacturing, had no significant difference from the titre obtained by FA within 24 months after manufacturing, being their pairs of observations positively correlated (r=0.49, p=0.0003), showing that the TS method, which anticipates the vaccines' performance at the end of the validity period, can substitute the FA method 24 months after manufacturing.
Orsi
Maria Angela
MA
National Agricultural Laboratory - Lanagro/SP - Ministry of Agriculture, Livestock and Food Supply - Campinas, SP, Brazil.
Zaroni
Margarida Maria H
MM
Doretto Júnior
Luciano
L
Camillo
Soraya Cecilia Albieri
SC
Ribeiro
Simone Alves Mendes
SA
Rosado Spilki
Fernando
F
Buzinaro
Maria da Glória
Mda G
Arns
Clarice Weis
CW
D000818:Animals; D001938:Brazil; D002645:Chickens / Q000097:blood / Q000276:immunology; D003080:Cold Temperature; D003132:Commerce; D004355:Drug Stability; D009521:Newcastle Disease / Q000276:immunology / Q000401:mortality / Q000517:prevention & control*; D013048:Specimen Handling / Q000009:adverse effects; D013997:Time Factors; D017186:Titrimetry; D016896:Treatment Outcome; D014765:Viral Vaccines / Q000737:chemistry / Q000627:therapeutic use*
D014765:Viral Vaccines